- Absci Corporation is a clinical-stage biopharmaceutical company focused on developing AI-designed therapeutics, particularly in the areas of androgenic alopecia and endometriosis, leveraging a unique generative AI platform to accelerate drug development.
- In the past year, Absci successfully advanced its lead clinical program, ABS-201, through three cohorts in the HEADLINE trial with favorable safety data, and appointed Dr. Ransi Somaratne as Chief Medical Officer to enhance its clinical development strategy.
- The company has partnered with U.S. soccer legend Landon Donovan to champion the patient voice in hair loss research, aiming to destigmatize androgenetic alopecia and promote awareness of its treatments.
- Absci's ideal buyers are pharmaceutical companies and research institutions seeking innovative, cost-effective drug development solutions, particularly those looking to address hair loss and related conditions with advanced AI technologies.
Engineering is Absci’s largest team with 98 employees, representing about 57 % of total headcount and underscoring the company’s emphasis on technology-driven drug discovery. Business Management follows with 22 employees (13 %), while Finance & Administration supports operations with 15 employees. Scientific and technical specialties—such as Healthcare (10 employees) and Information Technology (6 employees)—round out the research and infrastructure needs. Smaller groups in Operations, Sales & Support, Marketing & Product, and Legal collectively account for fewer than 10 % of staff, indicating lean commercial and corporate functions relative to R&D.
Absci’s workforce is distributed across multiple sites in the United States and Canada. The headquarters in Vancouver, Washington hosts the largest share at 52 employees, roughly 30 % of the total. Portland, Oregon is the second-largest hub with 47 employees, followed by a set of smaller satellite offices in New York, San Diego, Seattle, Boston, San Francisco, and Provo that together account for about 20 % of staff. An additional 42 employees are classified under “Other,” reflecting remote or flexible arrangements that give the company geographic reach beyond its core lab facilities.
